Bioventus Class A Inc (BVS)

Cost of Revenue

$47.54M

Quarterly · Period ending: · USD

BVS logo

BVS Cost of Revenue

Latest reported$47.54M
BVS Quarterly Cost of Revenue ($16.81M → $47.54M)
High-resolution chart · PNG

BVS cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bioventus Class A Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
47,542,000
42,427,000
50,415,000
45,820,000
47,009,000
42,413,000
50,986,000
45,413,000
47,578,000
41,077,000
49,122,000
41,944,000
47,946,000
45,140,000
51,645,000
44,127,000
43,677,000
41,588,000
42,646,000
29,821,000
33,503,000
22,222,000
25,121,000
23,444,000
17,668,000
21,409,000
24,125,000
21,684,000
22,563,000
22,563,000
19,235,000
16,807,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.